The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Lowered by Clearbridge Investments LLC

Clearbridge Investments LLC trimmed its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 13.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 293,997 shares of the medical device company’s stock after selling 44,912 shares during the period. Clearbridge Investments LLC owned 0.15% of Cooper Companies worth $27,027,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in COO. Fulton Bank N.A. grew its position in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after purchasing an additional 109 shares in the last quarter. Torray Investment Partners LLC grew its holdings in shares of Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock valued at $1,488,000 after acquiring an additional 132 shares in the last quarter. Mather Group LLC. grew its holdings in shares of Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after acquiring an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after acquiring an additional 136 shares during the last quarter. Finally, Greenleaf Trust raised its holdings in shares of Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after acquiring an additional 139 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Cooper Companies Price Performance

NASDAQ COO opened at $81.27 on Wednesday. The company has a market cap of $16.25 billion, a P/E ratio of 41.68, a P/E/G ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 1 year low of $77.05 and a 1 year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $88.87 and a 200 day simple moving average of $96.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Robert W. Baird dropped their target price on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Morgan Stanley dropped their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, BNP Paribas raised shares of Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.